APG101 in Glioblastoma

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Apogenix GmbH
ClinicalTrials.gov Identifier:
NCT01071837
First received: February 18, 2010
Last updated: June 15, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2014
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)